AI at the Crossroads: Will Hype Turn to Hope for Investors?
While the hype is spurring generative AI’s rapid development, there is still a risk AI could enter the "Trough of...
Travere’s Recent Breakthrough Drug Sends Its Stock Soaring: What Investors Need To Know Now!
Travere Therapeutics' completion of a successful pre-NDA meeting with the U.S. FDA for Filspari in IgA nephropathy has sent its...
Market Trends: Small-Cap Stocks in Technology, Healthcare, and Consumer Focused Sectors
Some of the best small cap options tend to lie within the technology, healthcare and consumer focused sectors due to...
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
DSS, Inc. (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder...
OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and...